Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms-Reference-Cited by-同舟云学术

Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms

Published:2019-07 Issue:7 Volume:25 Page:1293-1303
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Narayan Rupa,Benjamin Jonathan E.,Shah Omid,Tian Lu,Tate Keri,Armstrong Randall,Xie Bryan J.,Lowsky Robert,Laport Ginna,Negrin Robert S.,Meyer Everett H.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference48 articles.

1. TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors;Kohrt;Blood,2009

2. Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasms;Benjamin;Biol Blood Marrow Transplant,2014

3. Protective conditioning for acute graft-versus-host disease;Lowsky;N Engl J Med,2005

4. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses;Childs;Blood,1999

5. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning;Baron;Blood,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

2. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

3. How can Cytokine-induced killer cells overcome CAR-T cell limits;Frontiers in Immunology;2023-08-22

4. Potency assays and biomarkers for cell-based advanced therapy medicinal products;Frontiers in Immunology;2023-06-09

5. Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy;Transplantation and Cellular Therapy;2022-09